Clearance of triamcinolone from vitreous

G. N. Scholes, W. J. O'Brien, G. W. Abrams and M. F. Kubicek

The clearance of intravitreally injected triamcinolone acetonide was monitored by both indirect ophthalmoscopy and high-performance liquid chromatography (HPLC) and found to be more rapid than previously reported by others. Twenty-four rabbits were intravitreally injected in each eye with 0.4 mg of triamcinolone acetonide. Three rabbits each were sacrificed at intervals ranging from one hour to 46 days. The vitreous was then harvested and processed for HPLC analysis. Triamcinolone and the internal standard prednisolone were identified and quantitated by the use of HPLC, which was found to be both sensitive and specific for the steroids. The half-life as determined by HPLC was 1.6 days, the level at 13 days postinjection was 66 +/- 19 micrograms, and no drug was detectable by HPLC analysis at 21 days in five of six eyes. The intravitreal masses thought to be triamcinolone were clinically observable to an average of 23.3 days. The chromatographically determined clearance rate did not correlate well with clinical impressions based on indirect ophthalmoscopy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-term Retinal Toxicity of Intravitreal Commercially Available Preserved Triamcinolone Acetonide (Kenalog) in Rabbit Eyes
Albini et al.
IOVS 2007;48:390-395.
ABSTRACT | FULL TEXT  

Should corticosteroids be considered as part of the standard care with photodynamic therapy?
Zarbin
Arch Ophthalmol 2006;124:563-571.
FULL TEXT  

Pharmacokinetic-Pharmacodynamic Modeling of the Effect of Triamcinolone Acetonide on Central Macular Thickness in Patients with Diabetic Macular Edema
Audren et al.
IOVS 2004;45:3435-3441.
ABSTRACT | FULL TEXT  

Intravitreal Triamcinolone for the Treatment of Macular Edema Associated With Central Retinal Vein Occlusion
Ip et al.
Arch Ophthalmol 2004;122:1131-1136.
ABSTRACT | FULL TEXT  

Safety of an Intravitreal Injection of Triamcinolone: Results From a Randomized Clinical Trial
Gillies et al.
Arch Ophthalmol 2004;122:336-340.
ABSTRACT | FULL TEXT  

Feasibility of Drug Delivery to the Posterior Pole of the Rabbit Eye with an Episcleral Implant
Kato et al.
IOVS 2004;45:238-244.
ABSTRACT | FULL TEXT  

Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study
Sonoda et al.
Br. J. Ophthalmol. 2003;87:1010-1014.
ABSTRACT | FULL TEXT